Webinar Series on COVID-19 vaccination in immunocompromised patients
COVID-19 vaccination studies
From January 2021, 8 different studies have been initiated by ZonMw on COVID-19 vaccination in immunocompromised patients. These studies are taking place in different research Institutes within the Netherlands. To enable swift and efficient implementation of study-results ZonMw involves the National Institute for Public Health and Environment, the Ministry of Health and the Health Council of the Netherlands in the ongoing research process.
Together with our clients, policymakers, advisory bodies, researchers, patients, practice professionals, data professionals and international partners, ZonMw is working on possibilities to contribute research and knowledge, now and in the future, to solutions in the fight against the coronavirus and COVID-19 and the its effects on society.
In this Webinar, projectleaders dr. Virgil Dalm from Erasmus MC and dr. Inger Nijhof from Amsterdam UMC will share results from the VACOPID study: patients with primary immunodeficiencies and the COBRA-KAI study: patients with a haematological condition. Prof. dr. Martijn Luijsterburg will host this Webinar, together with Daniel Warmerdam.
Date and time
4 April 2022, 05:00 - 06:00 PM (GMT +1:00 Amsterdam).
Who can/ should sign up for the webinars?
This Webinar Series is aimed at transferring knowledge to an (inter)national audience of researchers, practitioners, informed patients and policy makers. The Webinar will therefore be offered in English.
Updated on: February 21th